Skip to main content
PolicySpeak
← All files
BMB

Bundesverband Medizintechnologie | BVMed e.V.

Industry association · Germany · EU Transparency Register 103122495301-83

3
positions filed
in the 326 files tracked
2
legislative files
of 326 tracked
3
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1205 trade and business associations on this site, they rank #598 by legislative files engaged — a count of participation, not a measure of influence.

2
declared lobbying FTE
self-declared
€100K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2024
in the register since

Declares membership of

  • VCI- Verband der chemischen Industrie
  • Aktionsbündnis Patientensicherheit e.V.
  • BMC - Bundesverband Managed Care e.V.
  • MedTech Europe →
  • Europäische Bewegung Deutschland e.V.
  • Forschungskuratorium Textil e.V.
  • Gesamtverband der deutschen Textil- und Modeindustrie e.V. →
  • Deutsche Kontinenz Gesellschaft e.V.
  • Bundesverband der Kommunikatoren e.V.
  • vbv - Vereinigung der Bayerischen Wirtschaft e.V.
  • DIN - Deusches Institut für Normung e.V.
  • DIN NamedNetzwerk
  • and 1 more

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Trade and business associations
Registered as
Bundesverband Medizintechnologie (BVMed)
Head office
Berlin, Germany

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Bundesverband in PolicySpeak: request access →

Work at Bundesverband Medizintechnologie | BVMed e.V.? so we know who speaks for it.

Follow the files Bundesverband Medizintechnologie | BVMed e.V. engages with

One email on Tuesdays when a new position is filed on these 2 files, from Bundesverband Medizintechnologie | BVMed e.V. or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Bundesverband Medizintechnologie | BVMed e.V. filed 3 positions between 4 Oct 2025 and 14 Jul 2026, across 2 of the 326 legislative files tracked here, attaching a full position paper 3 times.

2025 · 1 filed2026 · 2 filed

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 14 Jul 2026PDFsource

The targeted revision of the EU Medical Devices Regulation (MDR) is a crucial opportunity to make the European regulatory framework for medical devices more innovation-friendly, efficient and workable again, without compromising the high level of patient safety.

Filed in German · English published by the European Commission

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 4 Oct 2025PDFsource

The Bundesverband Medizintechnologie e.V. (BVMed) fully welcomes the European Commission’s ambition to streamline and future-proof the legal framework by reducing administrative burdens and increasing predictability and cost-effectiveness, while maintaining a high level of public health and patient safety, thereby contributing to the original objectives of the Regulations.

Filed in German · English published by the European Commission

Evaluation of the Biocidal Products Regulationfiled 4 Mar 2026PDFsource

Stellungnahme Verordnung über Biozidprodukte – Bewertung März 2026 Vorbemerkung Die Biozidprodukteverordnung (BPR, Verordnung (EU) Nr. 528/2012) ist ein zentrales Regelwerk für den Binnenmarkt, das seit 2013 die Zulassung und Verwendung von Biozidprodukten in der EU regelt.

Filed in German · English published by the European Commission

Opening of the attached position paper · the full paper is on the Commission’s record (source link above)

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Showing 5 of 7.

Is this your organization?

Everything on this page comes from Bundesverband Medizintechnologie | BVMed e.V.’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.